RNA Based Therapeutics Market to Reach $25.12 Bn, Globally, by 2030 at 17.6% CAGR: Allied Market Research

Rise in initiatives from government for large-scale sequencing projects drives the growth of the global RNA based therapeutics market.

News provided by

Allied Market Research

Jan 18, 2022, 08:40 ET

PORTLAND, Ore., Jan. 18, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "RNA Based Therapeutic Market by Disease Type (RNA interference (RNAi) and RNA antisense), Application (Genetic Disorders and Auto Immune Disorders) and End User (Research Institutes, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global RNA based therapeutics industry was estimated at $4.93 billion in 2021, and is anticipated to hit $25.12 billion by 2030, registering a CAGR of 17.6% from 2021 to 2030.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/546

Drivers, restraints, and opportunities-

Rise in initiatives from government for large-scale sequencing projects drives the growth of the global RNA based therapeutics market. On the other hand, hurdles in drug delivery, high cost of research, and threats of failure restrain the growth to some extent. However, early commercialization of pipeline therapeutics is expected to create lucrative opportunities in the industry.

Impact of COVID-19 on RNA Based Therapeutics Market-

There was a steep decline in the number of patients visiting clinics and hospitals for RNA based therapies, which, in turn, decreased the demand for RNA based therapeutic products, especially during the initial phase of the pandemic. This impacted the global RNA based therapeutic market negatively.

Also, mRNA vaccines could potentially offer long-term solutions all over the world for diseases ranging from influenza to AIDS, but owing to lockdown measures and temporary closure of research institutes and academic research, the demand for RNA based therapeutic solutions decreased significantly.
This trend is quite likely to continue till the pandemic is completely over.

Get detailed COVID-19 impact analysis on the RNA Based Therapeutic Market- https://www.alliedmarketresearch.com/request-for-customization/546?reqfor=covid

The RNA antisense segment to retain the lion's share-

On the basis of type, the RNA antisense segment held the major share in 2020, garnering nearly two-thirds of the global RNA based therapeutics market, due to increase in revenue of RNA antisense drug discovery and therapeutics. The RNA interference (RNAi) segment, on the other hand, is expected to register the fastest CAGR of 18.8% throughout the forecast period.

The genetic disorder segment to dominate by 2030-

On the basis of application, the genetic disorder segment contributed to the lion's share in 2020, holding more than three-fifths of the global RNA based therapeutics market, owing to surge in cases of genetic diseases, rare disorders, and molecular diagnostics. The same segment is also projected to manifest the fastest CAGR of 18.2% from 2021 to 2030. The report also analyzes the autoimmune disorder segment.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/546

North America held the major share in 2020-

By region, the market across North America dominated in 2020, garnering more than two-fifths the global RNA based therapeutics market. High expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region propel the market growth. Simultaneously, the Asia-Pacific region is also expected to cite the fastest CAGR of 18.9% throughout the forecast period. This is attributed to improvements in R&D facilities, available disposable income, and rapidly developing economic conditions.

Key players in the industry-

Silence Therapeutics plc.
Arbutus Biopharma Corporation
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals, Inc.
Benitec Biopharma Inc.
Genzyme (Sanofi), Arrowhead Pharmaceuticals
Biogen, Inc.
Gradalis, Inc.

Official Press Release: https://www.alliedmarketresearch.com/press-release/RNA-therapeutics-market-is-expected-to-reach-1-billion-globally-by-2020.html

Similar Research Reports for Information, Communication and Technology:

Paclitaxel-eluting Stent Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Hysteroscope Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Interventional Oncology Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Intraosseous Infusion Device Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Orthopedic Consumables Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter